Literature DB >> 23276972

The molecular pathogenesis of cholestasis in sepsis.

Harjit K Bhogal1, Arun J Sanyal.   

Abstract

Sepsis-induced cholestasis is a complication of infection. Infections cause systemic and intrahepatic increase in proinflammatory cytokines which result in impaired bile flow ie. cholestasis. Several other mediators of impairment in bile flow have been identified under conditions of sepsis such as increased nitric oxide production and decreased aquaporin channels. The development of cholestasis may also further worsen inflammation. The molecular basis of normal bile flow and mechanisms of impairment in sepsis are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23276972      PMCID: PMC4944118          DOI: 10.2741/e598

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  75 in total

1.  Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.

Authors:  Joyce J Repa; Knut E Berge; Chris Pomajzl; James A Richardson; Helen Hobbs; David J Mangelsdorf
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

2.  Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice.

Authors:  F K Welsh; C W Ramsden; K MacLennan; M B Sheridan; G R Barclay; P J Guillou; J V Reynolds
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

Review 3.  Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.

Authors:  Martin Wagner; Michael Trauner
Journal:  Ann Hepatol       Date:  2005 Apr-Jun       Impact factor: 2.400

4.  Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver.

Authors:  Andreas Geier; Christoph G Dietrich; Sebastian Voigt; Meenakshisundaram Ananthanarayanan; Frank Lammert; Anne Schmitz; Michael Trauner; Hermann E Wasmuth; Diana Boraschi; Natarajan Balasubramaniyan; Frederick J Suchy; Siegfried Matern; Carsten Gartung
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-04-28       Impact factor: 4.052

Review 5.  The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man.

Authors:  C C Paulusma; R P Oude Elferink
Journal:  J Mol Med (Berl)       Date:  1997-06       Impact factor: 4.599

6.  The causes of obvious jaundice in South West Wales: perceptions versus reality.

Authors:  M W Whitehead; I Hainsworth; J G Kingham
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

7.  Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.

Authors:  Marc Le Vee; Valérie Lecureur; Bruno Stieger; Olivier Fardel
Journal:  Drug Metab Dispos       Date:  2008-12-15       Impact factor: 3.922

8.  Altered expression of nuclear receptors affects the expression of metabolic enzymes and transporters in a rat model of cholestasis.

Authors:  Yoshitaka Hasegawa; Shuichi Kishimoto; Hirokazu Takahashi; Nobuo Inotsume; Yoshikazu Takeuchi; Shoji Fukushima
Journal:  Biol Pharm Bull       Date:  2009-12       Impact factor: 2.233

9.  A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.

Authors:  S S Strautnieks; L N Bull; A S Knisely; S A Kocoshis; N Dahl; H Arnell; E Sokal; K Dahan; S Childs; V Ling; M S Tanner; A F Kagalwalla; A Németh; J Pawlowska; A Baker; G Mieli-Vergani; N B Freimer; R M Gardiner; R J Thompson
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

10.  Increased iNOS activity is essential for hepatic epithelial tight junction dysfunction in endotoxemic mice.

Authors:  Xiaonan Han; Mitchell P Fink; Takashi Uchiyama; Runkuan Yang; Russell L Delude
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-08-28       Impact factor: 4.052

View more
  12 in total

Review 1.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

Review 2.  The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential.

Authors:  Xue Zhang; Hong Liu; Kenji Hashimoto; Shiying Yuan; Jiancheng Zhang
Journal:  Crit Care       Date:  2022-07-13       Impact factor: 19.334

Review 3.  Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease.

Authors:  Ting-Ying Jiao; Yuan-di Ma; Xiao-Zhen Guo; Yun-Fei Ye; Cen Xie
Journal:  Acta Pharmacol Sin       Date:  2022-02-25       Impact factor: 7.169

Review 4.  The Many Roles of Cholesterol in Sepsis: A Review.

Authors:  Daniel A Hofmaenner; Anna Kleyman; Adrian Press; Michael Bauer; Mervyn Singer
Journal:  Am J Respir Crit Care Med       Date:  2022-02-15       Impact factor: 30.528

Review 5.  [Monitoring of liver function in the critically ill].

Authors:  C Sponholz; F A Gonnert; A Kortgen; M Bauer
Journal:  Anaesthesist       Date:  2014-07       Impact factor: 1.041

6.  Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Padade M Vue; Wujuan Zhang; Kenneth D R Setchell; Saul J Karpen; Ronald J Sokol
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

7.  Gene silencing of non-obese diabetic receptor family (NLRP3) protects against the sepsis-induced hyper-bile acidaemia in a rat model.

Authors:  Y Wu; J Ren; B Zhou; C Ding; J Chen; G Wang; G Gu; X Wu; S Liu; D Hu; J Li
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

8.  Advances in sepsis-associated liver dysfunction.

Authors:  Dawei Wang; Yimei Yin; Yongming Yao
Journal:  Burns Trauma       Date:  2014-07-28

Review 9.  Function of aquaporins in sepsis: a systematic review.

Authors:  Katharina Rump; Michael Adamzik
Journal:  Cell Biosci       Date:  2018-02-09       Impact factor: 7.133

10.  Tracking Modified Vaccinia Virus Ankara in the Chicken Embryo: In Vivo Tropism and Pathogenesis of Egg Infections.

Authors:  Martin C Langenmayer; Anna-Theresa Lülf-Averhoff; Silvia Adam-Neumair; Gerd Sutter; Asisa Volz
Journal:  Viruses       Date:  2018-08-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.